Skip to main content
Home

Epocrates Online Contact us

  • Explore features
  • Reach clinicians
  • Buy now
By rray, 25 September, 2023

Any darr in BZD use beneficial if initial attempt unsuccessful treat underlying conditions and encourage subsequent taper attempt3

By rray, 25 September, 2023

Avoid uarr dose or prn use of BZD once taper initiated7

By rray, 25 September, 2023

If taper of short acting BZD intolerable consider switch to longer acting BZD diazepam if

By rray, 25 September, 2023

Follow q1 4wk 2 3 7 monitor for w d sx and treat symptomatically 2 3 5 pause slow taper if needed1 3 5 7

By rray, 25 September, 2023

Rapid taper of alprazolam or abrupt switching not recommended due to w d sz risk1 3 7

By rray, 25 September, 2023

A more rapid taper e g darr by 25 of original dose qwk may be appropriate if respiratory depression risk or evidence of misuse diversion2 3

By rray, 25 September, 2023

Shorter taper darr by 10 to 15 of original dose qwk x4wk until 50 of original dose reached then maintain that dose x1 2mo then darr by 25 of remaining dose q2wk consider if low dose BZD use for

By rray, 25 September, 2023

Longer taper darr by 10 of original dose no faster than q2 4wk 1 3 7 recommended to prevent severe w d and aid in BZD d c 1 longer or high dose BZD use warrants longer taper1 7

By rray, 25 September, 2023

Individualize gradual taper via shared decision making 2 6 provide written taper schedule 1 2 7 taper rate determined by w d sx severity1 3

By rray, 25 September, 2023

Consider specialist referral if substance use d o hx severe medical or psychiatric d o high dose BZD 4 concurrent stimulant or opioid use drug w d sz hx2 3

Pagination

  • First page
  • Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page
  • Last page

About Us

  • Company Overview
  • Media Relations
  • Contact
  • Editorial Policy
  • Editorial Process
  • Third-Party Sponsorship Policy
  • athenahealth

Products

  • Core Products
  • Mobile CME
  • Product Licenses

Business Solutions

  • Pharma
  • Market Research
  • Institutions

Support

  • Support Center
  • Install
  • My Account

Stay Connected

Facebook Twitter YouTube

Patient Resource Footer Bottom

  • Privacy Policy
  • Terms of Use
  • Site Map